Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

183
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
183
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151
Pneumothorax-II01:27

Pneumothorax-II

120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
120

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Artificial intelligence-based algorithm for predicting outcomes in early-stage lung cancer: An annotation-free imaging artificial intelligence study.

JTCVS open·2026
Same author

Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Left upper lobectomy for lung cancer with a subaortic anomalous left brachiocephalic vein: a case report.

General thoracic and cardiovascular surgery cases·2026
Same author

Histological Features of Lung Squamous Cell Carcinoma According to Radiological Early-Phase Progression Patterns.

Pathology international·2026
Same author

Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

相关实验视频

Updated: Jun 3, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.8K

Pleural mesothelioma 的预后指标是什么

Masaya Yotsukura1, Yukihiro Yoshida1, Kazuo Nakagawa1

  • 1Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.

Annals of thoracic surgery short reports
|January 10, 2025
PubMed
概括

对于恶性多叶膜间皮瘤,像强迫生命能力 (FVC) 这样的肺功能测试是关键. 低FVC预测生存率较低,在成像不清楚时有助于做出手术决定.

科学领域:

  • 胸部外科手术 胸部外科手术
  • 肺部医学 肺部医学
  • 在瘤学瘤学.

背景情况:

  • 恶性多叶层层层瘤在通过成像评估瘤进展方面存在挑战.
  • 需要独立于成像的客观指数来评估瘤负担和手术候选性.

研究的目的:

  • 为了确定恶性多间皮瘤的客观预后因素.
  • 评估临床因素对预测术后存活率的有用性.

主要方法:

  • 追溯分析79名患有恶性多层间皮瘤的患者进行手术.
  • 评估临床因素,包括预测的强迫生命能力 (FVC) 的百分比和成像发现.

主要成果:

  • 预测低百分比的FVC (<80%) 是整体存活率差的唯一显著的独立预测因素 (HR 2.76,P=.01).
  • 与FVC≥80% (76.6%) 的患者相比,FVC<80% (16.6%) 的患者的两年生存率显着较低.
  • 图像检测结果和病理阶段在多变量分析中显示出较少显著的预后价值.

结论:

  • 预测的百分比FVC是恶性多叶膜间皮瘤中术后生存的强大,成像独立的预测指标.
  • FVC评估有助于评估瘤入侵和指导手术指示.

更多相关视频

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.1K

相关实验视频

Last Updated: Jun 3, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.8K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.1K